Machine learning to predict post-therapy dosimetry for 177Lu-PSMA I&T treatment

被引：0
|
作者：
Shi, K. [1 ]
Xue, S. [1 ]
Gafita, A. [2 ]
Dong, C. [2 ]
Zhao, Y. [2 ]
Tetteh, G. [2 ]
Menze, B. H. [2 ]
Afshar-Oromieh, A. [1 ]
Eiber, M. [2 ]
Rominger, A. [1 ]
机构：
[1] Univ Bern, Bern, Switzerland
[2] Tech Univ Munich, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-441
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [31] Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
    Yusufi, Nahid
    Wurzer, Alexander
    Herz, Michael
    D'Alessandria, Calogero
    Feuerecker, Benedikt
    Weber, Wolfgang
    Wester, Hans-Juergen
    Nekolla, Stephan
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (08) : 1106 - 1111
  • [32] PSMA avidity-based recurrent patterns after 177Lu-PSMA I&T in metastatic castration-resistant prostate cancer
    Kwon, S.
    Rauscher, I.
    D'Alessandria, C.
    Eiber, M.
    Weber, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S655 - S655
  • [33] Radioligand Therapy with [177Lu]Lu-PSMA I&T in the Elderly - Safety, Efficacy and Prognosticators of Survival
    Weber, S.
    Seitz, A.
    Kuebler, H.
    Buck, A. K.
    Werner, R. A.
    Hartrampf, P. E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S151 - S151
  • [34] Estimating 177Lu-PSMA Radiopharmaceutical Therapy Tumor Dosimetry from PET: Implications for Improving Treatment Response
    Hesterman, Jacob
    Orcutt, Kelly
    Hoppin, Jack
    Kuo, Phillip
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [35] Dose Calculations and Dose-Effect Relationships in 177Lu-PSMA I&T Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
    Barna, Sandra
    Haug, Alexander R.
    Hartenbach, Markus
    Rasul, Sazan
    Grubmueller, Bernhard
    Kramer, Gero
    Blaickner, Matthias
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (09) : 661 - 667
  • [36] PSMA Radioligand Therapy of Metastasized Prostate Cancer Using Lu-177 PSMA I&T and Lu-177 PSMA-617: First comparative Dosimetric Results
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Shahinfar, M.
    Singh, A.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S36 - S37
  • [37] Pre- or Post-Chemotherapy: Effect of 177Lu-PSMA Radioligand Therapy on PSMA Expression
    Yadav, Surekha
    Heath, Courtney Lawhn
    Juarez, Roxanna
    De Kouchkovsky, Ivan
    Aggarwal, Rahul
    Hope, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [38] Simplified Organ and Tumor Dosimetry for Lu-177-PSMA-I&T Radionuclide Therapy
    Lehnert, W.
    Schatz, L.
    Karimzadeh, A.
    Apostolova, I.
    Buchert, R.
    Klutmann, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S745 - S746
  • [39] The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival
    Acar, Emine
    Ozdogan, Ozhan
    Aksu, Aysegul
    Derebek, Erkan
    Bekis, Recep
    Kaya, Gamze Capa
    ANNALS OF NUCLEAR MEDICINE, 2019, 33 (09) : 681 - 688
  • [40] Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [177Lu]Lu-PSMA-I&T 177 Lu]Lu-PSMA-I&T Therapy
    Resch, Sandra
    Ziegler, Sibylle I.
    Sheikh, Gabriel
    Unterrainer, Lena M.
    Zacherl, Mathias J.
    Bartenstein, Peter
    Boening, Guido
    Brosch-Lenz, Julia
    Delker, Astrid
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (08) : 1272 - 1278
12345